Search

Your search keyword '"Greninger A"' showing total 2,618 results

Search Constraints

Start Over You searched for: Author "Greninger A" Remove constraint Author: "Greninger A"
2,618 results on '"Greninger A"'

Search Results

52. SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

53. Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

54. A landscape of response to drug combinations in non-small cell lung cancer

55. Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivo.

57. Exploring the Utility of Multiplex Infectious Disease Panel Testing for Diagnosis of Infection in Different Body Sites: A Joint Report of the Association for Molecular Pathology, American Society for Microbiology, Infectious Diseases Society of America, and Pan American Society for Clinical Virology

58. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection

59. Sentinel Surveillance System Implementation and Evaluation for SARS-CoV-2 Genomic Data, Washington, USA, 2020-2021

60. Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA

61. Experimental induction of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) inoculated with brain homogenates containing avian bornavirus 4

62. The complete genome of klassevirus – a novel picornavirus in pediatric stool

63. Risk of COVID-19 after natural infection or vaccination

65. Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

66. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: Identification of a candidate etiologic agent

67. CrAssphage and its bacterial host in cat feces

68. Risk of COVID-19 after natural infection or vaccinationResearch in context

69. Cryptic transmission of SARS-CoV-2 in Washington state

70. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California

71. A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage

72. Optimized workplace risk mitigation measures for SARS-CoV-2 in 2022

73. Sentinel Surveillance System Implementation and Evaluation for SARS-CoV-2 Genomic Data, Washington, USA, 2020–2021

74. Human Parainfluenza Virus in Homeless Shelters before and during the COVID-19 Pandemic, Washington, USA

75. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study

77. Genomic Analysis of Early Monkeypox Virus Outbreak Strains, Washington, USA

79. Genomic Analysis of Early Monkeypox Virus Outbreak Strains, Washington, USA

80. Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells

81. Human Parainfluenza Virus in Homeless Shelters before and during the COVID-19 Pandemic, Washington, USA

83. Severe acute respiratory syndrome coronavirus 2 seroprevalence and longitudinal antibody response following natural infection in pregnancy: A prospective cohort study

84. COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave

85. Near-Universal Resistance to Macrolides of Treponema pallidum in North America

86. The kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children

87. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

89. Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy.

90. SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model

91. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine

93. Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike.

94. Virology under the Microscope—a Call for Rational Discourse

95. Treponema pallidum subsp. pallidum with an Artificially impaired TprK antigenic variation system is attenuated in the Rabbit model of syphilis.

99. Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

100. Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection

Catalog

Books, media, physical & digital resources